Education
About Us
Working with TipRanks
Follow Us
Abivax SA (GB:0RA9)
LSE:0RA9
Total Valuation
Abivax SA has a market cap or net worth of €431.55M. The enterprise value is €386.64M.
Market Cap€431.55M
Enterprise Value€386.64M
Share Statistics
Abivax SA has 63,471,930 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding63,471,930
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Abivax SA’s return on equity (ROE) is -4.34 and return on invested capital (ROIC) is -114.42%.
Return on Equity (ROE)-4.34
Return on Assets (ROA)-0.86
Return on Invested Capital (ROIC)-114.42%
Return on Capital Employed (ROCE)-1.65
Revenue Per Employee156.41K
Profits Per Employee-2.55M
Employee Count69
Asset Turnover0.05
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Abivax SA is -2.42. Abivax SA’s PEG ratio is -0.19.
PE Ratio-2.42
PS Ratio0.00
PB Ratio10.66
Price to Fair Value10.50
Price to FCF-2.78
Price to Operating Cash Flow-2.78
PEG Ratio-0.19
Income Statement
In the last 12 months, Abivax SA had revenue of 10.79M and earned -176.24M in profits. Earnings per share was -2.80.
Revenue10.79M
Gross Profit10.79M
Operating Income-185.43M
Pretax Income-182.89M
Net Income-176.24M
EBITDA-167.68M
Earnings Per Share (EPS)-2.80
Cash Flow
In the last 12 months, operating cash flow was -155.51M and capital expenditures -640.00K, giving a free cash flow of -156.15M billion.
Operating Cash Flow-155.51M
Free Cash Flow-156.15M
Free Cash Flow per Share-2.46
Dividends & Yields
Abivax SA pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.37
52-Week Price Change-45.92%
50-Day Moving Average6.01
200-Day Moving Average7.04
Relative Strength Index (RSI)62.52
Average Volume (3m)9.71K
Important Dates
Abivax SA upcoming earnings date is Aug 11, 2025, Before Open (Confirmed).
Last Earnings DateJun 2, 2025
Next Earnings DateAug 11, 2025
Ex-Dividend Date―
Financial Position
Abivax SA as a current ratio of 1.84, with Debt / Equity ratio of 237.03%
Current Ratio1.84
Quick Ratio1.84
Debt to Market Cap0.22
Net Debt to EBITDA0.28
Interest Coverage Ratio-13.14
Taxes
In the past 12 months, Abivax SA has paid -6.65M in taxes.
Income Tax-6.65M
Effective Tax Rate0.04
Enterprise Valuation
Abivax SA EV to EBITDA ratio is -2.26, with an EV/FCF ratio of -2.45.
EV to Sales35.15
EV to EBITDA-2.26
EV to Free Cash Flow-2.45
EV to Operating Cash Flow-2.46
Balance Sheet
Abivax SA has €144.22M in cash and marketable securities with €96.19M in debt, giving a net cash position of -€48.03M billion.
Cash & Marketable Securities€144.22M
Total Debt€96.19M
Net Cash-€48.03M
Net Cash Per Share-€0.76
Tangible Book Value Per Share€0.25
Margins
Gross margin is 100.00%, with operating margin of -1718.24%, and net profit margin of -1633.08%.
Gross Margin100.00%
Operating Margin-1718.24%
Pretax Margin-1694.71%
Net Profit Margin-1633.08%
EBITDA Margin-1553.76%
EBIT Margin-1563.95%
Analyst Forecast
The average price target for Abivax SA is €17.60, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target€17.60
Price Target Upside155.44% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast―
EPS Growth Forecast―